EGFR (Epidermal Growth Factor Receptor) inhibitors
- Name
- EGFR (Epidermal Growth Factor Receptor) inhibitors
- Accession Number
- DBCAT005725
- Description
Not Available
- ATC Classification
- Drugs
Drug Drug Description Cetuximab An endothelial growth factor receptor binding fragment used to treat colorectal cancer as well as squamous cell carcinoma of the head and neck. Panitumumab A recombinant humanized monoclonal antibody used to treat EGFR-expressing, metastatic colorectal carcinoma that is refractory to fluoropyrimidine-, oxaliplatin-, and irinotecan- containing chemotherapy regimens. Necitumumab A monoclonal antibody used to treat metastatic squamous non-small cell lung cancer. - Drugs & Drug Targets